Advances in PET/CT Imaging for Breast Cancer-Reference-Cited by-同舟云学术

Advances in PET/CT Imaging for Breast Cancer

Published:2023-07-07 Issue:13 Volume:12 Page:4537
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

de Jong Dorine¹^ORCID,Desperito Elise²,Al Feghali Karine³,Dercle Laurent²^ORCID,Seban Romain-David⁴⁵^ORCID,Das Jeeban⁶,Ma Hong²,Sajan Abin²,Braumuller Brian²,Prendergast Conor²,Liou Connie²,Deng Aileen⁷,Roa Tina²,Yeh Randy⁶,Girard Antoine⁸^ORCID,Salvatore Mary²,Capaccione Kathleen²

Affiliation:

1. Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA

2. Department of Radiology, Columbia University Irving Medical Center, New York, NY 10032, USA

3. RefleXion Medical, Inc., Hayward, CA 94545, USA

4. Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210 Saint-Cloud, France

5. Laboratory of Translational Imaging in Oncology, Paris Sciences et Lettres (PSL) Research University, Institut Curie, 91401 Orsay, France

6. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA

7. Department of Hematology and Oncology, Novant Health, 170 Medical Park Road, Mooresville, NC 28117, USA

8. Department of Nuclear Medicine, Centre Eugène Marquis, Université Rennes 1, 35000 Rennes, France

Abstract

One out of eight women will be affected by breast cancer during her lifetime. Imaging plays a key role in breast cancer detection and management, providing physicians with information about tumor location, heterogeneity, and dissemination. In this review, we describe the latest advances in PET/CT imaging of breast cancer, including novel applications of 18F-FDG PET/CT and the development and testing of new agents for primary and metastatic breast tumor imaging and therapy. Ultimately, these radiopharmaceuticals may guide personalized approaches to optimize treatment based on the patient’s specific tumor profile, and may become a new standard of care. In addition, they may enhance the assessment of treatment efficacy and lead to improved outcomes for patients with a breast cancer diagnosis.

Publisher

MDPI AG

Subject

General Medicine

Link

https://www.mdpi.com/2077-0383/12/13/4537/pdf

Reference214 articles.

1. Cancer statistics, 2017. CA: A Cancer;Siegel;J. Clin.,2017

2. Understanding breast cancer as a global health concern;Wilkinson;Br. J. Radiol.,2022

3. United Nations Development Programme (2021, January 27). Human Development Data Center. Available online: http://hdr.undp.org/en/data.

4. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

5. Cancer Research UK (2021, August 31). Breast Cancer Statistics. Available online: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head-to-Head Comparison of [18F]PSMA-1007 and [18F]FDG PET/CT in Patients with Triple-Negative Breast Cancer;Cancers;2024-02-04

2. Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-14

3. An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data;Cancers;2023-11-20